GSE158431 2 V 6 PIOGLITAZONE MOUSE DN (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE158431 2 V 6 PIOGLITAZONE MOUSE DN.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE158431 2 V 6 PIOGLITAZONE MOUSE DN.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE158431 2 V 6 PIOGLITAZONE MOUSE DN.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE158431 2 V 6 PIOGLITAZONE MOUSE DN.

Results found

Linked to

 

Label

Description

 

Gene

valyl-tRNA synthetase 1

Gene

mitochondrial ribosomal protein S18B

Gene

WD repeat domain 46

Gene

coiled-coil domain containing 112

Gene

glycine cleavage system protein H

Gene

Rho GTPase activating protein 40

Gene

twist family bHLH transcription factor 2

Gene

solute carrier family 6 member 9

Gene

patched domain containing 1

Gene

bridge-like lipid transfer protein family member 3B

  • Gene

    valyl-tRNA synthetase 1


  • Gene

    mitochondrial ribosomal protein S18B


  • Gene

    WD repeat domain 46


  • Gene

    coiled-coil domain containing 112


  • Gene

    glycine cleavage system protein H


  • Gene

    Rho GTPase activating protein 40


  • Gene

    twist family bHLH transcription factor 2


  • Gene

    solute carrier family 6 member 9


  • Gene

    patched domain containing 1


  • Gene

    bridge-like lipid transfer protein family member 3B

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.